etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG

RxCUI: 2626788
RxNorm name: etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG
Display name: etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG
Full name: etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125772	Hemgenix	etranacogene dezaparvovec-drlb	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
HEMGENIX	ETRANACOGENE DEZAPARVOVEC	CSL Behring	35b2db65-4c6c-4173-ab56-b2bca69193bd	2026-05-01	Warnings, Adverse reactions	Exact identifier rxcui: 2626788

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
35b2db65-4c6c-4173-ab56-b2bca69193bd	{14 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack [GPCK] · etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG [PSN] · etranacogene dezaparvovec-drlb Kit Patient Weight 66 - 70 KG [SY]	3	8	These highlights do not include all the information needed to use HEMGENIX safely and effectively. See full prescribing information for HEMGENIX. HEMGENIX (etranacogene dezaparvovec-drlb) suspension, for intravenous infusion Initial U.S. Approval: 2022	20260501